Paschal Emeka, Abuja
Dr. Monica Eimunjeze has been appointed the new Director General of the National Agency for Food and Drug Administration and Control (NAFDAC) as the tenure of Professor Moji Adeyeye as Director General of NAFDAC comes to an end.
Recall that President Muhammadu Buhari appointed Prof. Adeyeye in November 2017 as DG NAFDAC for a renewable five-year term.
A November 17th, 2022 memo by Director of Human Resources Management, A. U. Oboli, informed units and departments of Adeyeye’s replacement.
The communication with reference number NAFDAC/ADM/SM/075 was addressed to the directors.
Oboli informed them that the government had appointed Dr. Monica Eimunjeze as the Acting Director General with effect from November 12.
“I am, therefore, directed to bring this development to you for information and guidance,” she added.
The new head of the agency studied Pharmacy at Ahmadu Bello University (ABU) Zaria and graduated in 1986.
She obtained a Doctor of Pharmacy degree from Mercer University in Atlanta, and a Master of Science (M.Sc.) in Biotechnology, Innovation and Regulatory Science from Purdue University.
Eimunjeze has years of experience in the pharmaceutical sector. She had her industrial exposure with GlaxoSmithKline from 1989 to 1996.
She was previously NAFDAC Director of Registration and Regulatory Affairs, Director of Drug Evaluation and Research, as well as Technical Assistant to the DG.